Novel noninvasive liver fibrotic markers to predict postoperative re-bleeding after laparoscopic splenectomy and azygopo

  • PDF / 1,509,335 Bytes
  • 8 Pages / 595.276 x 790.866 pts Page_size
  • 79 Downloads / 155 Views

DOWNLOAD

REPORT


and Other Interventional Techniques

Novel noninvasive liver fibrotic markers to predict postoperative re‑bleeding after laparoscopic splenectomy and azygoportal disconnection: a 1‑year prospective study Long‑Fei Wu1,2 · Xiao‑Xing Xiang3 · Dou‑Sheng Bai1 · Sheng‑Jie Jin1 · Chi Zhang1 · Bao‑Huan Zhou1 · Jian‑Jun Qian1 · Guo‑Qing Jiang1  Received: 18 June 2020 / Accepted: 16 October 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020

Abstract Background  Esophagogastric variceal re-bleeding (EGVR) is a common and potentially lethal complication after open or laparoscopic splenectomy and azygoportal disconnection (LSD) in patients with cirrhosis and portal hypertension. Currently, noninvasive biomarkers for predicting EGVR are lacking. This prospective study focused on developing a noninvasive and convenient clinical model for predicting postoperative EGVR. Methods  Between September 2014 and March 2017, we enrolled 164 patients with cirrhosis who successfully underwent LSD. Based on the absence or presence of EGVR, patients were divided into EGVR and non-EGVR groups. We used correlation analysis to determine significant candidate variables among the liver fibrotic markers procollagen type III (PC-III), hyaluronidase (HA), laminin (LN), and type IV collagen (C-IV). Results  Postoperative EGVR occurred in 22 (13.41%) patients. Correlation analyses showed that LN (r = 0.375; p